Mr ADAM H. ROSSMB ChB, FRCOphth, FHEA, CertMedEd

• 2011

  FRCOphth
  Royal College of Ophthalmology, London

• 2010

  Post Graduate Certificate in Teaching & Learning for Health Professionals (TLHP)
  University of Bristol

• 2010

  Fellow of the Higher Education Academy

• 2007

  MRCOphth
  Royal College of Ophthalmology, London

• 2003

  Bachelor of Medicine & Surgery (MBChB)
  University of Bristol

• 1997

  4 Advanced (“A”) Levels
  Mander Portman Woodward, London

• 1995

  9 GCSEs
  University College School, London
  Music Scholar

• 2011

  Alcon Glaucoma Case Competition Finalist

• 2009

  Winner of South Western Ophthalmological Society (SWOS) prize for best published paper

• 2005

  Nominated to represent South West in RCOphth Congress Regional Round-up

• 2004

  Winner of South Western Ophthalmological Society (SWOS) prize for best oral presentation

• 2001

  Nominated for the University of Bristol Arthritis Research Campaign Student Prize

• 1998

  Awarded AEB prize for Statistics for being within top 5 people in the UK

Distinctions & Merits during undergraduate career

• Ophthalmology
• ENT
• Anaesthetics
• Dermatology
• Pathology
• Medicine & Surgery

Bursaries

• Elective Bursary for ‘Comparison of the education of visually impaired children between Melbourne & Independent Samoa’ - The Lord Mayor’s 800^th Anniversary Trust – London

Specialist Trainee Programme / Specialist Registrar – Ophthalmology Severn Deanery

• August 2012 – Nov 2012

  Medical Retina & Uveitis US Visiting Fellowships
  1. Vitreous Retina Macular Consultants of New-York
  2. NIH, Washington

• August 2011 – August 2012

  Medical Retina & Uveitis Fellowship
  Bristol Eye Hospital

• Feb 2011 – August 2011

  Paediatric Ophthalmology
  Cheltenham General Hospital

• August 2010 – Feb 2011

  Medical Retina
  Cheltenham General Hospital

• Feb 2010 – August 2010

  Glaucoma
  Cheltenham General Hospital

• August 2009 – Feb 2010

  Oculoplastics
  Cheltenham General Hospital

• Feb 2009 – August 2009

  Academic Retina
  Bristol Eye Hospital

• August 2008 – Feb 2009

  Glaucoma
  Bristol Eye Hospital

• Feb 2008 – August 2008

  Oculoplastics
  Bristol Eye Hospital

• August 2007 – Feb 2008

  Vitreo-retinal
  Bristol Eye Hospital

• Feb 2007 – August 2007

  Medical Retina
  Bristol Eye Hospital

• August 2006 – Feb 2007

  Plastics, Strabismus & Paediatrics
  Bristol Eye Hospital

• Feb 2006 – August 2006

  Cornea (Anterior Segment)
  Bristol Eye Hospital

• August 2005 – Feb 2006

  Vitreo-retinal & Uveitis
  Bristol Eye Hospital

• April 2005 – August 2005

  Glaucoma
  Bristol Eye Hospital

• Feb 2005 – April 2005

  Demonstrator of Anatomy - University of Bristol
  Department of Anatomy
  MRC Centre for Synaptic Plasticity (Neuroscience)

Responsible for teaching neuroanatomy, head and neck and general anatomy to 1st and 2nd year medical students as well as dental students. Heavy emphasis on teaching using dissected and prosected specimens.

• August 2004 – Feb 2005

  Senior House Officer – Emergency Medicine
  Cheltenham General Hospital

• Feb 2004 – August 2004

  House Physician – Cardiology & Coronary Care Unit
  North Bristol NHS Trust, Southmead Hospital

• August 2003 - Feb 2004

  House Surgeon – General Surgery
  Weston General Hospital

1. Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 update
   Eye – in press 2017
   Praveen J. Patel¹, Helen Devonport², Sobha Sivaprasad¹, Adam Ross³, Gavin Walters⁴, Richard Gale⁵, Andrew Lotery⁶, Sajjad Mahmood⁷, James Talks⁸, Jackie Napier
2. Application of OCT-angiography to characterise the evolution of chorioretinal lesions in acute posterior multifocal placoid pigment epitheliopathy.
   Eye – in press 2017
   TR Burke1, CJ Chu1,2, S Salvatore1, C Bailey1, AD Dick1,2,3, RWJ Lee1,2,3, AH Ross1 and
E Carreño1
3. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.
   Lancet. 2017 May 5. pii: S0140-6736(17)31193-5. doi: 10.1016/S0140-6736(17)31193-5. [Epub ahead of print]
   Part of CLARITY Study Group.
4. Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis.
   Makragiannis G, Vahdani K, Carreño E, Lee RW, Dick AD, Ross AH.
   Int Ophthalmol. 2017 Mar 30. doi: 10.1007/s10792-017-0502-
5. Multimodal Imaging in Acute Posterior Multifocal Placoid Pigment Epitheliopathy Demonstrating Obstruction of the Choriocapillaris.
   Salvatore S, Steeples LR, Ross AH, Bailey C, Lee RW, Carreño E.
   Ophthalmic Surg Lasers Imaging Retina. 2016 Jul 1;47(7):677-81
6. Phase IIb clinical trial of ranibizumab for the treatment of uveitic and idiopathic choroidal neovascular membranes Carreño E, Moutray T, Fotis K, Lee RW, Dick AD, Ross AH, Bailey C.. Br J Ophthalmol. 2015 Dec 16.
7. Managing Juvenile Idiopathic Arthritis-associated Uveitis.
   Hawkins MJ, Dick AD, Lee RJ, Ramanan AV, Carreño E, Guly CM, Ross AH.
   Surv Ophthalmol. 2015 Oct 24.
8. Localized choroidal thickness variation and pigment epithelial detachment in dome-shaped macula with subretinal fluid.
   Deobhakta A, Ross AH, Helal J Jr, Maia A, Freund KB.
   Ophthalmic Surg Lasers Imaging Retina. 2015 Mar;46(3):391-2.
9. Aflibercept in wet AMD beyond the first year of treatment: recommendations by an expert roundtable panel.
   McKibbin M1, Devonport H2, Gale R3, Gavin M4, Lotery A5, Mahmood S6, Patel PJ7, Ross A8, Sivaprasad S7, Talks J9, Walters G10.
   Eye (Lond). 2015 Jul;29 Suppl 1:S1-S11
10. Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency.
    Zarranz-Ventura J, Carreño E, Johnston RL, Mohammed Q, Ross AH, Barker C, Fonollosa A, Artaraz J, Pelegrin L, Adan A, Lee RW, Dick AD, Sallam A
    Am J Ophthalmol. 2014 Dec;158(6):1136-1145.e5.
11. Running an Efficient Neo-Vascular Age Related Macular Degeneration Hospital Service Eye. Eye (Lond). 2013 Jan;27(1):56-64
    Ross AH, Sallam A, Mohammed Q, Kirkpatrick N, & Johnston RL.
12. Review of Central Serous Retinopathy
    Curr Opin Ophthalmol. 2011 May;22(3):166-73. Review.
    Ross A, Ross AH, Mohamed Q
13. Management of diabetic macular oedema – invited review.
    Saudi Journal of Ophthalmology. 2011 Vol 25(2):123-129
    Ross AH, Bailey CC.
14. Diabetic Retinopathy Review for BMJ Clinical Evidence
    Clin Evid (Online). 2011 May 25
    Mohamed Q, Ross AH, Chu C.
15. Review and Update of Intra-operative Floppy Iris Syndrome.
    Expert Review of Ophthalmology. 2011 Vol 6 (4):469-476.
    Sallam A, Ross AH, Bashir SJ, Towler HMA.
16. Review and Update of Involuntary Facial Movement Disorders Presenting in the
    Ophthalmological Setting.
    Survey of Ophthalmology. 2010 Jan-Feb;56(1):54-67
    Adam H Ross, John S Elston, Marie-Helene Marion, & Raman Malhotra.
17. Non Arteritic Anterior Ischaemic Optic Neuropathy in Addison’s Disease.
    Eye (Lond). 2010 Oct;24(10)
    Ross AH, Haider S, Bailey CC.
18. Analysis of the diurnal intraocular pressure profile pre- and post- trabeculectomy
    using 24-hour monitoring of intraocular pressure: a retrospective case-control study.
    European Journal of Ophthalmology 2010 Oct 14
    Ross AH, Jackson TE, Wertheim MS, Spry PGD, Sparrow JM, Diamond JP.
19. Management of upper eyelid cicatricial entropion.
    Clin Experiment Ophthalmol. 2011 Aug;39(6):526-36
    Ross AH, Cannon PS, Selva D & Malhtora R.
20. Lateral orbital wall ossifying fibroma.
    Orbit. 2010 Dec;29(6):317-20
    Wakefield M, Ross AH, Damato EM, Salvi SM, Baker GCR.
21. The use of Imiquimod in the treatment of periocular tumours.
    Orbit. 2010 Apr;29(2):83-7.
    Ross AH, Kennedy C, Collins C, Harrad RA.
22. Long-term topical steroid treatment following penetrating keratoplasty in
    patients with pseudophakic bullous keratopathy.
    Ophthalmology 2009 Dec;116(12):2369-72
    Ross AH, Jones MNA, Nguyen DQ, Jaycock PD, Armitage WJ, Cook SD, Kaye SB, Tole DM.
23. Lacrimal gland uptake of Gallium (67Ga) Citrate in patients without ocular pathology.
    Orbit. 2009;28(2-3):120-3.
    Ross AH, Herbert HM, Kabala JM & Malhotra R.
24. Long-term orbitofacial complications of polyalkylimide 4% (Bio-Alcamid) –
    migration, infection and recurrent swelling.
    Ophthal Plast Reconstr Surg. 2009 Sep-Oct;25(5):394-7.3.
    Ross AH, Malhotra R.
25. Topical Cyclosporin - A Treatment for Corneal Graft Rejection. Invited editorial.
    Clinical and Experimental Ophthalmology 2008 Vol 36(5):399-400.
    Ross AH & Cook SD.
26. Diamonds are forever !
    Eye 2009 May:23(5): 1228
    Ross AH., Wertheim M.S., Dick A.D. & Majid M.A.
27. Downbeat nystagmus related with epidural opioid side effect.
    Acute Pain 2008 10; 93-95.
    Ruiz G, Orts A, Monsalve J, Aliste P, Ross AH & Monsalve B.
28. Comparison of the quality of referrals and listing rates of traditional GP referrals & Optometric direct referrals for cataract surgery.
    Eye – Epub ahead of print 08 Feb 2008
    Park, J., Ross, A.H., Sparrow, J.M., Tole, D.M. & Mundasad, M.
29. Delayed choroidal haemorrhage with concomitant sub-conjunctival haemorrhage following retinal detachment surgery.
    RETINAL Cases & Brief Reports. 2(2):121-123, Spring 2008.
    Ross, A.H., Biswas, S. & Haynes, R.J.
30. The use of Rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.
    Br J Ophthalmol. 2009 Apr;93(4):421-2, 548.
    Ross, A.H, Jaycock, P., Cook, S.D, Dick, A.D. & Tole, D.M.
31. The use of Campath in severe peripheral ulcerative keratitis associated with Wegeners granulomatosis.
    Eye 2006. 20, 1453 - 1454 .
    Wertheim, M.S, Ross, A.H. & Tole, D.M.
32. In vivo measurement of opacified H60M intraocular lenses using Scheimpflug photography.
    British Journal of Ophthalmology 2006;90:1328-1329.
    Ross, A.H., Mundasad, M.V., Mayer, E.J., Sparrow, J.M., Dick, A.D. & Tole, D.M.
33. Traumatic callosomarginal aneurysm following orbital gunshot wound in a 16-year-old girl.
    British Journal of Neurosurgery 2007(1) 1-2.
    Barua, N.U., Ross, A.H. & Sandeman, D.R.
34. Comment on ‘Long-term Corticosteroid Eye Drops after Penetrating Keratoplasty: A Prospective, Randomized, Clinical Trial.’
    Ophthalmology – in press (2012)
    Ross AH, Knox-Cartwright NE, Cook SD, Armitage WJ & Tole DM.
35. Ethambutol optic neuropathy
    BMI (Minerva Case) – in press. (2012)
    Ross AH, Uys C, Mcnaught AI.
36. APMPPE
    BMJ (Minerva Case) 201;343
    Ross AH, Baker GRC, Martin RJ, Mohamed Q.
37. Ross AH www.phacotutorials.info (RH Caesar) Contribution to evidence based section of latter website.
38. Ophthalmopaedia (RCOphth) (March,2010).
    Blepharospasm & Hemi-Facial Spasm.
39. Ophthalmopaedia (RCOphth) (March,2010).
    Ophthalmic manifestations of Neurofibromatosis. (March,2010).

1. Award from Professor Dame Sally Davies for NIHR Clinical Research Network Leading Commercial Prinicpal Investigators (2016)
2. Uveitis Research Clinic - I lead a weekly uveitis research clinic, taking in referrals from the South-West region and promoting current clinical research trials at the Bristol Eye Hospital.
3. Samsung Bioepis/SB11-G31-AMD - Chief Investigator
4. GILEAD - Filgotiniib trial  -  PI
5. Abbott Uveitis Study - Efficacy and Safety of Adalimumab in Subjects With Active /Inactive Uveitis (Visual I and II).
6. COMO Study - A 12-month masked study comparing the safety and efficacy of ozurdex versus ranibizumab in branch retinal vein occlusion.
7. TREND Study -PI
8. CLARITY Study - PI
9. LAEVO Study - PI
10. Active involvement in all Bristol Eye Hospital clinical research trials including:
    • RETAIN - Efficacy and safety of 0.5 mg ranibizumab in two “treat and extend” Treatment Algorithms vs. 0.5 mg ranibizumab as needed in patients with DME.
    • MERLOT ­- Macular EpiRetinal Brachytherapy versus Lucentis only treatment.
    • PATHOLOGICAL MYOPIA - Ranibizumab for the treatment of CNV secondary to pathological myopia.
    • INFLAMMATORY CNVM – Ranibizumab treatment for inflammatory CNVM.
    • NOVA22007  - A phase III, multicentre, randomised controlled, double-masked trial of NOVA22007 (Ciclosporin 0.1%) ophthalmic cationic emulsion versus vehicle in patients with moderate to severe dry eye syndrome.
    • IVAN – Efficacy of monthly intravitreal Ranibizumab versus Bevacizumab in AMD.
    • SAKURA – Safety and Efficacy of intravitreal Sirolimus in the treatment of active non-infectious posterior uveitis.
    • VISUAL I / VISUAL II - Efficacy and Safety of Adalimumab in Subjects With Active /Inactive Uveitis.
    • COMO - A 12-month masked study comparing the safety and efficacy of ozurdex versus ranibizumab in branch retinal vein occlusion.
    • MATISSE – Dose escalation study and evaluation of PF-04523655 with/without Ranibizumab in DME.

    Furthermore, I have personally helped to design a proforma to aid active recruitment into the uveitis clinical trials at the Bristol Eye Hospital.

11. Does glaucoma surgery alter the diurnal intraocular pressure profile ? –
    Ross, A.H, Spry, P., Diamond, J.D & Sparrow, J.M. (2007)
    The study is now complete and published in 2010.

    I personally set up this study at the Bristol Eye Hospital, including all R&D and ethics applications, clinical recruitment and ensured that the results were published in the medical literature.

12. Ross, A.H, Singhal, P., Grey, R.H.B. & Mundasad, M. (2006) Analysis of medical factors associated with diabetic maculopathy in laser treated patients; long term follow up.

    Lead role in research carried out in conjunction with department of Medicine and Ophthalmic surgery along with Dr Parag Singhal (Weston General Hospital) and Mr Rodney Grey.

13. R.S. Khan, Ross, A.H, Galloway, P., Johnston, R. & Johnson, B. (2004) Hal, should I drive my car?
    Assessment of a computerised classification of the Esterman driving visual field test.
    Department of Ophthalmology, Cheltenham General Hospital and St. James University Hospital, Leeds. 

Qualifications

• Post Graduate Certificate in Teaching & Learning for Health Professionals (TLHP) The University of Bristol (2010)
• Fellow of the Higher Education Academy The Higher Education Academy (2010)

Formal

• Lead Coordinator/Organiser for University of Bristol Undergraduate Ophthalmology Programme (2011 onwards)

  This has involved independent attendance at University of Bristol committee meetings, managing students and timetables during their ophthalmology placements, setting university examinations, invigilation and associated pastoral care.

• Demonstrator of Anatomy – University of Bristol, Department of Anatomy, MRC Centre for Synaptic Plasticity (Neuroscience)
• Design and implementation of Ophthalmology University of Bristol E-learning seminars (MDEMO module)
• Regular supervisor for UoB undergraduate ophthalmology special study modules (SSCs)
• Training of nurse practitioner to perform YAG lasers and intravitreal injections.
• Ophthalmology & Primary Care for GP registrars
• Invited speaker for qualified GP Ophthalmology courses in Cheltenham & Bristol
• Ophthalmology courses for final year medical students
• Regular 3^rd year Ophthalmology medical student lectures
• Examiner for 5^th year medical student examinations
• Ophthalmology lectures to nurses/nurse practitioners
• Regular grand round and journal club teacher
• Small group tutorials on a regular basis
• Organisation of OSCE practice for final year students
  

Informal

• Teaching and supervising of juniors/other fellows performing ophthalmological procedures including AC taps/ retinal lasers and PDT.
• Teaching methods of Slit-Lamp use and basic corneal foreign body removal to A&E Senior House Officers/Junior Ophthalmologists & nurses.
• Regular bedside teaching to medical students, including examination technique and practical procedures.
• Teaching of cannulation technique to nurses.

1. Polypoidal choroidal vasculopathy audit/QiP (2017)
   Bristol Eye Hospital April 2017
2. Outcome of Antivegf treatment for retinal vein occlusion (2016)
   Bristol Eye Hospital
3. Aflibercept for the treatment of wet age-related macular degeneration (2015)
   Bristol Eye Hospital
4. Outcomes of Ranibizumab Treatment for Neo-Vascular Age Related Macular Degeneration.
   Ross AH & Johnston RL. (2011/2012)
   Outcome: Published – Eye. 
   Poster presentation RCOphth May 2012
5. Re-audit: Is simple punctal stenosis appropriately assessed and treatment effective. (2009)
   Ross AH, Herbert HM, Baker G. 
   Outcome:  Findings presented at BEH Audit Meeting
6. Management of non-ischaemic Central Retinal Vein Occlusion. Bristol Eye Hospital. (2008)
   Ross AH, Hughes S, Majid MA & Mundasad.
   Outcome:  Findings presented at BEH Audit Meeting
7. Comparison of the quality of referrals and listing rates of traditional GP referrals
   & Optometric direct referrals for cataract surgery. 
   Park, J., Ross, A., Sparrow, J.M., Tole, D.M. & Mundasad, M. (2006)   
   Outcome:  Published paper
8. Ross, A., Mundasad, M., Cook, S. & Tole, D. Assessing the visual, refractive and
   symptomatic benefit of Phototherapeutic Keratectomy.  (2005)
   Outcome:
   • Prize Winning Presentation at SWOS meeting.
   • Nominated for South West presentation in RCOphth Congress Regional Round-up, May 2005
9. Visual outcome of laser treatment for diabetic maculopathy. (2004) 
   Ross, A., Grey, R.H.B. (2004)
   Department of Ophthalmology, Weston General Hospital. 
   Outcome:  Findings presented at SWOS, BEH Audit meetings and Karnataka State Conference, India.

1. FFA GRAND ROUNDS -  Unilateral IRVAN.   RCOphth College Congress 2012
2. Results of at least 1 year’s treatment with ranibizumab for treatment-naïve eyes with neovascular ARMD
   South Western Ophthalmological Society (SWOS) meeting November 2011
3. Triple S Procedure
   BOPSS June 2010
4. Long-term topical steroid treatment following penetrating keratoplasty in patients with pseudophakic bullous keratopathy.
   Oxford Ophthalmological Congress, Oxford.  June 2009.
5. Phototherapeutic Keratectomy.
   Oxford Ophthalmological Congress, Oxford.  June 2008.
6. Clinical Outcome of Phototherapeutic Keratectomy.
   24^th Annual Karnataka State Ophthalmic Conference, Bangalore, India. 2005.
7. Laser Treatment for diabetic maculopathy & associated prognostic medical factors. 
   24^th Annual Karnataka State Ophthalmic Conference, Bangalore, India. 2005.
8. Laser Treatment for diabetic maculopathy & associated prognostic medical factors.
   South Western Ophthalmological Society (SWOS) Meeting, Bristol, 2005.
9. Ciliary Body Clefts.
   Bristol Eye Hospital, April 2005.
10. Endophthalmitis Update.
    Bristol Eye Hospital, June 2005.
11. Clinical Outcome of Phototherapeutic Keratectomy for Treatment of Anterior Corneal Diseases. 
    European Society of Cataract & Refractive Surgery (ESCRS), Rome, 2005.
12. Analysis of medical factors associated with diabetic maculopathy in laser treated patients; long term follow up. 
    Bristol Eye Hospital Meeting, 2004.
13. Visual outcome of laser treatment for diabetic maculopathy.
    Bristol Eye Hospital Meeting,  November 2004.
14. Clinical Outcome of Phototherapeutic Keratectomy.
    Bristol Eye Hospital Audit Meeting, July 2004.
15. Clinical Outcome of Phototherapeutic Keratectomy.
    South Western Ophthalmological Society (SWOS) Meeting, Bristol, June 2004.

1. Ozurdex treatment for RVO – experience at the Bristol Eye Hospital.
   Giannopoulos T, Rehman A, Kaitantzis A, Fotis K & Ross AH.
   South Western Ophthalmological Society (SWOS) Meeting, Bristol, January 2013.
2. Which visual acuity measurements define high quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?
   Ross AH,  Mohamed Q, Kirkpatrick N, Johnston RL.
   RCOphth 2012.
3. One-Year Results of Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration in the NHS.
   Ross AH,  Mohamed Q, Kirkpatrick N, Sallam A, Harney B, Johnston RL.
   RCOphth 2010.
4. Lacrimal gland uptake of Gallium (67Ga) Citrate in patients without ocular pathology.
   Ross AH, Herbert HM, Kabala JM & Malhotra R.
   BOPSS (Cambridge) 2009.
5. The use of Imiquimod in the treatment of periocular tumours. 
   Ross AH, Kennedy C, Collins C, Harrad RA
   BOPSS (Cambridge) 2009.
6. Lacrimal gland uptake of Gallium (67Ga) Citrate in patients without ocular pathology.
   Ross AH, Herbert HM, Kabala JM & Malhotra R.
   RCOphth 2009.
7. Clinical outcomes of Photo-therapeutic Keratectomy.
   Ross, AH, Tole, DM, Majid MA & Mundasad MV.
   Oxford Ophthalmological Congress, Oxford.  June 2008.
8. Visual outcome of laser treatment for diabetic maculopathy.
   Ross, A., Grey, R.H.B.
   European Association for the Study of Diabetes (EASD), Athens, 2005.
9. Hal, should I drive my car? : Assessment of a computerised classification of the Esterman driving visual field test.
   Khan R.S., Ross, A., Galloway, P., Johnston, R. & Johnson, B.
   Royal College of Ophthalmology Congress, Birmingham, May 2005.
10. In vivo measurement of opacified H60M intraocular lenses using Scheimpflug photography.
    Ross, A.H., Mundasad, M.V., Mayer, E.J., Sparrow, J.M., Dick, A.D. & Tole, D.M.
    South Western Ophthalmological Society (SWOS) Meeting, Bristol, June 2006.
11. The use of Rituximab in refractory mucous membrane pemphigoid with severe ocular involvement.
    Ross, A.H, Jaycock, P., Cook, S.D, Dick, A.D. & Tole, D.M.
    South Western Ophthalmological Society (SWOS) Meeting, Bristol, June 2007.

1. Visiting Fellowships

   I have carried out various international visiting fellowships:

   • National Institute for Health Research (NIHR) in the National Eye Institute (NEI) under the supervision of Dr Emily Chew and Dr Robert Nussenblatt. The NEI is part of the National Institutes of Health and leads the US government's research on the visual system and eye diseases. NEI supports basic and clinical science programmes that result in the development of sight-saving treatments.

     Dr Emily Chew specialises in medical retina, in particular age-related macular degeneration, diabetic retinopathy, nutrition and vision as well as epidemiology of the aforementioned.  Dr Chew currently chairs the Age-Related Eye Disease Study 2 (AREDS 2), which is testing supplements containing plant- and fish-derived nutrients for preventing advanced age-related macular degeneration. She also chairs the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study, which is looking at the effects of tight blood sugar, lipid, and blood pressure control on diabetic retinopathy.

     Dr Nussenblatt serves as a world-class ocular immunologist whose main interest is within uveitis as well as the role of inflammation in causing age-related macular degeneration (AMD).

   • Vitreous-Retina-Macular Consultants of New York (VRMNY) under the medical retina team, including Lawrence Yannuzzi, Jason Slakter and Richard Spaide. This is a centre of excellence for medical retina, both clinically as well as in research and contains many world-renowned retinal specialists.

2. Neuro-ophthalmology

   In 2010, I spent a short visiting fellowship working along side Dr Gordon Plant at the National Hospital for Neurology and Neurosurgery, Moorfields Eye Hospital and at St. Thomas’ Hospital in London.

3. Journal Reviewer

   I have reviewed for a variety of ophthalmology journals including EYE, OPRS and Clinical Ophthalmology.

1. Ophthalmology Adviser for British National Formulary (BNF) and BNF for Children (BNFC) - 2012 onwards.
2. Lead Consultant for AMD Service – Bristol Eye Hospital.
3. Lead Coordinator/Organiser for University of Bristol Undergraduate Ophthalmology Programme – 2011 onwards
   Since 2011, I have coordinated the undergraduate ophthalmology teaching programme at UoB.  I have built a team of enthusiastic teachers who are motivated to improve teaching as reflected by continually improving feedback.
4. Clinical Research Meetings
   I participate in the weekly managerial meetings for the Clinical Research Unit at the Bristol Eye Hospital.
5. Educational supervision of SSC’s for multiple University of Bristol medical students
6. Managerial / Administrative Responsibility for junior involvement in NHS work carried out by CESP/New-medica – Bristol Eye Hospital 2007 – 2009.
7. Bristol University Interviewer for undergraduate/postgraduate entry into Bristol Medical School – Bristol 2005
8. Administrative Specialist Trainee - Bristol Eye Hospital 2008
   This involved rota, on-call and timetable management for the junior doctors.
9. Senior House Officer Administrator Role – Bristol Eye Hospital 2006
   This involved rota, on-call and timetable management for the junior doctors.
10. Mess Manager – Weston General Hospital 2004
    Responsibility for fund management and accounts; organisation/promotion of mess activities.
11. Music
    I have taken on managerial roles throughout my music interests.  I have led various orchestras at the National Association of Young String Players and at the Royal College of Music, London.  In addition, I have set-up, participated in and managed chamber music groups.  This has involved regular rehearsals, concert organisation and charitable fund raising events.